Yahoo
OTC Markets OTCQX - Delayed Quote USD

DSM-Firmenich AG (DSFIY)

12.03 +0.13 (+1.09%)
As of 9:57:07 AM EST. Market Open.
Chart Range Bar
Loading chart for DSFIY
  • Previous Close 11.90
  • Open 12.08
  • Bid 12.01 x 534400
  • Ask 12.06 x 320000
  • Day's Range 12.03 - 12.08
  • 52 Week Range 6.40 - 12.36
  • Volume 101
  • Avg. Volume 200,646
  • Market Cap (intraday) 29.397B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.63
  • Earnings Date --
  • Forward Dividend & Yield 2.00 (16.84%)
  • 1y Target Est 11.34
  • Zacks Rating Bullish

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.

www.dsm-firmenich.com

20,786

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

DSFIY
55.68%
AEX-Index (^AEX)
19.05%

1-Year Return

DSFIY
53.10%
AEX-Index (^AEX)
16.58%

3-Year Return

DSFIY
5.79%
AEX-Index (^AEX)
53.87%

5-Year Return

DSFIY
5.79%
AEX-Index (^AEX)
39.43%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 3.18B
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
0.0%

Analyst Insights

View More

Analyst Price Targets

11.34 Low
11.34 Average
12.03 Current
11.34

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.23%

  • Return on Assets (ttm)

    1.23%

  • Return on Equity (ttm)

    1.87%

  • Revenue (ttm)

    9.05B

  • Net Income Avi to Common (ttm)

    324M

  • Diluted EPS (ttm)

    -0.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.31B

  • Total Debt/Equity (mrq)

    37.64%

  • Levered Free Cash Flow (ttm)

    -18.38M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: